SCHEMBL4924642

SCHEMBL4924642

CCOC(=O)c1cc(C(=O)c2sc(S(C)(=O)=O)c3c2CC(C)(C)CC3=O)on1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.52
PKM P14618 2/20 0.52
LMNA P02545 4/20 0.45
MAPT P10636 3/20 0.45
KDM4E B2RXH2 1/20 0.45
LRRK2 Q5S007 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
OPRM1 P35372 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927639 0.88 LRRK2 (0.44) ALDH1A1PKMLMNAMAPTKDM4E
SCHEMBL7433903 0.82 ALDH1A1 (0.73) ALDH1A1PKMLMNAMAPTKDM4E
SCHEMBL4922740 0.78 LRRK2 (0.41) ALDH1A1PKMLMNAMAPTLRRK2
SCHEMBL13791613 0.73 ALDH1A1 (0.54) ALDH1A1PKMLMNAMAPTKDM4E
SCHEMBL4927720 0.73 LRRK2 (0.48) ALDH1A1PKMLMNAMAPTKDM4E
SCHEMBL4923725 0.72 ALDH1A1 (0.51) ALDH1A1PKMLMNAKDM4ELRRK2
SCHEMBL4929001 0.71 LRRK2 (0.45) ALDH1A1PKMLMNAMAPTLRRK2
SCHEMBL4923028 0.71 ALDH1A1 (0.50) ALDH1A1PKMLMNAMAPTKDM4E
SCHEMBL4923124 0.71 LRRK2 (0.45) ALDH1A1PKMMAPTKDM4ELRRK2
SCHEMBL4929382 0.71 ALDH1A1 (0.50) ALDH1A1PKMLMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
EP-1765814-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2007-03-28 EP disclosed
WO-2006003096-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists GLP1R, GIPR, GCGR ALDH1A1 2002/4885PKM 2177/4885LMNA 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.